Last $0.78 HKD
Change Today -0.01 / -1.27%
Volume 190.0K
8189 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 3:01 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin teda biomedical-h (8189) Snapshot

Open
$0.79
Previous Close
$0.79
Day High
$0.80
Day Low
$0.78
52 Week High
02/10/14 - $1.03
52 Week Low
11/10/14 - $0.56
Market Cap
1.1B
Average Volume 10 Days
410.0K
EPS TTM
$0.01
Shares Outstanding
705.0M
EX-Date
--
P/E TM
44.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANJIN TEDA BIOMEDICAL-H (8189)

Related News

No related news articles were found.

tianjin teda biomedical-h (8189) Related Businessweek News

No Related Businessweek News Found

tianjin teda biomedical-h (8189) Details

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, is engaged in the research, development, manufacture, and sale of biological compound fertilizer products and health care products in the People’s Republic of China. It operates in two segments, Compound Fertilizers Products and Health Care Products. The company markets its biological compound fertilizer products under the Fulilong brand, which are used for the balanced growth of grains, fruits, and vegetables. It also offers a series of health care products under the Alpha brand comprising diabetic health care products and related products with the function of regulating the blood sugar level; and various sugar-free products, including beverages, low glucose cookies, cereals, calcium-rich milk powder, and mooncakes. The company was founded in 2000 and is headquartered in Tianjin, the People's Republic of China.

560 Employees
Last Reported Date: 03/25/14
Founded in 2000

tianjin teda biomedical-h (8189) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: CNY485.6K
Vice Chairman
Total Annual Compensation: CNY447.2K
Qualified Accountant and Company Secretary
Total Annual Compensation: CNY150.0K
Compensation as of Fiscal Year 2013.

tianjin teda biomedical-h (8189) Key Developments

Tianjin TEDA Biomedical Engineering Company Limited Announces Earnings Results for the Nine Months Ended September 30, 2014

Tianjin TEDA Biomedical Engineering Company Limited announced earnings results for the nine months ended September 30, 2014. For the nine months, the company's profit attributable to owners of the company was RMB 13.56 million, or 0.96 cents per basic share, compared to RMB 14.66 million, or 1.03 cents per basic share, for the same period ended September 30, 2013. Turnover was RMB 425.37 million, compared to RMB 465.82 million for the same period ended September 30, 2013.

Tianjin TEDA Biomedical Engineering Company Limited Announces Earnings Results for the Third Quarter Ended September 30, 2014

Tianjin TEDA Biomedical Engineering Company Limited announced earnings results for the third quarter ended September 30, 2014. For the quarter, the company revealed turnover of CNY 148 million, climbing 1.3% from a year earlier. Net profit reached CNY 4.01 million, rising 61.5%. EPS were CNY 0.0028.

Tianjin TEDA Biomedical Engineering Company Limited to Report Q3, 2014 Results on Nov 13, 2014

Tianjin TEDA Biomedical Engineering Company Limited announced that they will report Q3, 2014 results on Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8189:HK $0.78 HKD -0.01

8189 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8189.
View Industry Companies
 

Industry Analysis

8189

Industry Average

Valuation 8189 Industry Range
Price/Earnings 43.8x
Price/Sales 1.7x
Price/Book 4.2x
Price/Cash Flow 43.8x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TEDA BIOMEDICAL-H, please visit www.bioteda.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.